Financial Times Special Report Examines Efforts To Develop Novel Coronavirus Vaccine, Impacts On World’s Poor, Campaign To Address Antimicrobial Resistance

Financial Times: FT Health: Combating Coronavirus
In this special report, the Financial Times “look[s] at efforts to ensure that the world’s poor are not left behind [in the race to develop a novel coronavirus vaccine] — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance” (Multiple authors, 5/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.